17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases
The Journal of Clinical Endocrinology & Metabolism · 17.03.2025 · 110 (4) · e1261-e1271
DOI: 10.1210/clinem/dgae773 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 06.11.2024. Verfasst von Annabelle L Willemsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Notre Dame Australia, Sydney 2010, Australia. Hauptthemen laut MEDLINE: Steroid 17-alpha-Hydroxylase, Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Adelaide Hospital Mary Overton Early Career Research Fellowship, Royal Australian College of Physicians Fellows Research Establishment Fellowship, Endocrine Society of Australia Postdoctoral Award.
Abstract (Originalsprache)
Purpose
Homozygous pathogenic variants in the CYP17A1 gene result in defective activity of the steroidogenic enzymes 17α-hydroxylase/17,20-lyase resulting in the clinical syndrome 17-OHD characterized by hypertension, hypokalemia, and disorders of sexual development. Pathogenic variants of CYP17A1 lead to complete or partial loss of enzymatic activity and clinical presentations of varying severity. This study aimed to examine relationships between CYP17A1 genotype and clinical presentation in a global cohort.
Methods
We searched PubMed and Scopus for case reports and cohort studies reporting clinical data on patients with 17-OHD published between 1988 and 2022. Of 451 studies, 178 met inclusion criteria comprising a total of 465 patients. We pooled patient data and examined associations between causative variants and their clinical presentations.
Results
There were 465 unique patients with a mean age of 18.9 (9.0) years, 52.5% (n = 244) were XY and 6.4% (n = 29) were phenotypically male. Homozygous variants were seen in 48.0% (n = 223) of patients. Common clinical presentations were hypertension (57.0%, n = 256), hypokalemia (45.4% n = 211), primary amenorrhea (38.3%, n = 178), cryptorchidism (15.3%, n = 71), and atypical genitalia (14.2%, n = 66). Frequently occurring variants included p.Y329Kfs (n = 86), p.D487_F489del (n = 44), and p.W406R (n = 39). More severe variants, such as p.Y329Kfs, were associated with hypocortisolism (P < .05), combined hypokalemia and hypertension (P < .01), and disordered sexual development (P < .01). Main conclusion 17-OHD is a rare, frequently misdiagnosed disease. Male patients are typically diagnosed earlier because of genital dysplasia associated with less severe variants, whereas female patients are typically diagnosed later from primary amenorrhea and hypertension. Patients presenting with disordered sexual development and hypertension should be investigated for 17-OHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Notre Dame Australia, Sydney 2010, Australia.
- Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide 5000, Australia.
- South Australian Adult Genetics Unit, Royal Adelaide Hospital, Adelaide 5000, Australia.
- Adelaide Medical School, University of Adelaide, Adelaide 5005, Australia.
- Department of Molecular Medicine and Surgery, Karolinska Intitutet, Stockholm 171 77, Sweden.
- Department of Endocrinology, Karolinska University Hospital, Stockholm 171 77, Sweden.
ORCID-Profile: Annabelle L Willemsen, Henrik Falhammar
Förderung
- Royal Adelaide Hospital Mary Overton Early Career Research Fellowship
- Royal Australian College of Physicians Fellows Research Establishment Fellowship
- Endocrine Society of Australia Postdoctoral Award
- Karolinska Institutet and the Stockholm County Council
Zitieren
APA
Willemsen, A. L., Torpy, D. J., De Sousa, S. M. C., Falhammar, H., & Rushworth, R. L. (2025). 17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases. The Journal of Clinical Endocrinology & Metabolism, 110(4), e1261-e1271. https://doi.org/10.1210/clinem/dgae773
Vancouver
Willemsen AL, Torpy DJ, De Sousa SMC, Falhammar H, Rushworth RL. 17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases. The Journal of Clinical Endocrinology & Metabolism. 2025;110(4):e1261-e1271. doi:10.1210/clinem/dgae773
BibTeX
@article{Willemsen2025,
author = {Willemsen, Annabelle L and Torpy, David J and De Sousa, Sunita M C and Falhammar, Henrik and Rushworth, R Louise},
title = {17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {4},
pages = {e1261--e1271},
doi = {10.1210/clinem/dgae773}
}
EUVIMED